BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference
Oncology company BeOne Medicines has announced its participation in the upcoming Morgan Stanley Annual Global Healthcare Conference. The company plans to host a fireside chat to discuss its research, development, and clinical-stage manufacturing.
Why it matters
Investor conferences are key indicators of corporate strategy and potential market shifts in the pharmaceutical sector.
BeOne Medicines Ltd. (NASDAQ: ONC ; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Morgan Stanley Annual Global Healthcare Conference on September 14, 2026, with a fireside chat at 11:30 a.m. EDT.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901309669/en/
BeOne Medicines ' flagship clinical and commercial-stage manufacturing and research and development facility in Hopewell, N.J.
The live webcast of this event can be accessed from the investors section of the Company's website at https://ir.beonemedicines.com . An archived webcast will be available on the Company's website.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in